Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about GlobalPharmacyMeds.to
List of countries where we can ship Dronedarone:
Latest news releases on Dronedarone:
Dronedarone (development codename SR33589 and marketed as Multaq) is a drug by Sanofi-Aventis, mainly for the indication of cardiac arrhythmias. It was approved by ...
Physician reviewed dronedarone patient information - includes dronedarone description, dosage and directions.
MULTAQ : MULTAQ est indiqué pour le maintien du rythme sinusal après une cardioversion réussie chez les patients adultes cliniquement stables atteints de ...
Amiodarone effectively maintains sinus rhythm in patients with atrial fibrillation, but although dronedarone is less effective it has a better safety profile.
第28卷第1期 Mar. 31 2012 新藥 Dronedarone 應用於心房纖維顫動和心房撲動之治療 藥學雜誌 第110冊 33 繼續教育 但不含碘,可降低對 ...
Careful monitoring during dronedarone administration is recommended by regular assessment of cardiac, hepatic and pulmonary function (see below).
5.4 QT Interval Prolongation . Dronedarone induces a moderate (average of about 10 ms but much greater effects have been observed) QTc (Bazett) prolongation
Find a comprehensive guide to possible side effects including common and rare side effects when taking Multaq (Dronedarone Tablets) for healthcare professionals and ...
Dronedarone is metabolized by CYP 3A and is a moderate inhibitor of CYP 3A and CYP 2D6 and has potentially important pharmacodynamic interactions . Class I or III ...
StopAfib examines the pros and cons of Multaq (dronedarone) for atrial fibrillation (afib)